- Home
- BRLT vs AIFF Comparison
BRLT vs AIFF Comparison
Compare BRLT & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- AIFF
- Stock Information
- Founded
- BRLT 2005
- AIFF 2006
- Country
- BRLT United States
- AIFF Canada
- Employees
- BRLT N/A
- AIFF N/A
- Industry
- BRLT Consumer Specialties
- AIFF
- Sector
- BRLT Consumer Discretionary
- AIFF
- Exchange
- BRLT Nasdaq
- AIFF NYSE
- Market Cap
- BRLT 27.2M
- AIFF 26.6M
- IPO Year
- BRLT 2021
- AIFF N/A
- Fundamental
- Price
- BRLT $1.95
- AIFF $2.64
- Analyst Decision
- BRLT Buy
- AIFF
- Analyst Count
- BRLT 4
- AIFF 0
- Target Price
- BRLT $3.00
- AIFF N/A
- AVG Volume (30 Days)
- BRLT 80.0K
- AIFF 57.7K
- Earning Date
- BRLT 11-07-2024
- AIFF 11-14-2024
- Dividend Yield
- BRLT N/A
- AIFF N/A
- EPS Growth
- BRLT N/A
- AIFF N/A
- EPS
- BRLT 0.03
- AIFF N/A
- Revenue
- BRLT $426,982,000.00
- AIFF $74,000.00
- Revenue This Year
- BRLT N/A
- AIFF N/A
- Revenue Next Year
- BRLT $2.47
- AIFF N/A
- P/E Ratio
- BRLT $70.97
- AIFF N/A
- Revenue Growth
- BRLT N/A
- AIFF N/A
- 52 Week Low
- BRLT $1.52
- AIFF $2.46
- 52 Week High
- BRLT $3.81
- AIFF $15.90
- Technical
- Relative Strength Index (RSI)
- BRLT 54.22
- AIFF 42.03
- Support Level
- BRLT $1.93
- AIFF $2.89
- Resistance Level
- BRLT $2.04
- AIFF $3.25
- Average True Range (ATR)
- BRLT 0.12
- AIFF 0.26
- MACD
- BRLT 0.00
- AIFF -0.02
- Stochastic Oscillator
- BRLT 64.86
- AIFF 23.03
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.